Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Tesla (TSLA.US) Robotaxi faces another regulatory challenge: investigation over speeding in school zones, casting a shadow over Cybercab expansion

Tesla (TSLA.US) Robotaxi faces another regulatory challenge: investigation over speeding in school zones, casting a shadow over Cybercab expansion

智通财经智通财经2026/10/12 13:41
Show original
```htmlGolden Ten Data APP reports that Tesla (TSLA.US)'s Robotaxi business is once again under review by US regulatory agencies. The National Highway Traffic Safety Administration (NHTSA) is evaluating allegations about Tesla's Cybercab and Model Y driverless taxis speeding in school zones. As Tesla accelerates the expansion of its autonomous vehicle fleet, the latest regulatory developments add new uncertainty to the commercialization process of its Robotaxi business.```
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Amgen (AMGN.US) and AstraZeneca (AZN.US) combination therapy extends small cell lung cancer survival by eight months, reduces risk of death by 58%

Researchers combined Amgen's Imdelltra with AstraZeneca's Imfinzi and found that for patients with aggressive lung cancer whose tumors had already spread, this combination extended survival by about eight months compared to Imfinzi monotherapy. Small cell lung cancer is one of the cancer types with the worst prognosis.

智通财经•2026/10/25 02:56
Amgen (AMGN.US) and AstraZeneca (AZN.US) combination therapy extends small cell lung cancer survival by eight months, reduces risk of death by 58%